A business strategy focused on maintaining and strengthening the leading market share and position in the knee osteoarthritis market, centered on Gel-One, ARTZ, OPEGAN products and the next-generation product SI-613. It covers the expansion of sales volume for existing products and US sales together with the development of next-generation products.